Prefilled Syringes MarketSize and Trends

Global Prefilled Syringes Market is estimated to be valued at US$ 6.44 billion in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030). Increase in launch of products by key market players is expected to drive the market growth over forecast period. Moreover, increase in prevalence of chronic and infectious diseases is expected to drive the market growth over forecast period (2023-2030).

Figure 1.Global Prefilled Syringes Market Share (%), by Drug Type, 2023

Figure 2. Global Prefilled Syringes Market Share (%), by Region, 2023

Global Prefilled Syringes Market Segmentation:

The Global Prefilled Syringes Market report is segmented into material, drug type, design, product type, usability, manufacturing method, end user and region

Based on Material, the market is segmented into Glass and Plastic/Polymer. Out of which, Plastic/polymer segment is expected to dominate the prefilled syringes market during the forecast period and this is attributed due to rising demand and increasing approvals by regulatory bodies for plastic syringes.

Based on Drug Type, the market is segmented into Biologics, Vaccines, Insulin, Anticoagulants, Flush Saline Syringes and Others. Out of which, Biologics segment is expected to dominate the market over the forecast period and this is attributed to increasing investments by key market players for establishing new facilities in order to increase the manufacturing capacity of biologics.

Based on Design, the prefilled syringes market is segmented into Single-chamber, Dual-chamber and Multi-chambered. Single-chamber segment is expected to dominate the market over the forecast period and this is attributed to increase in the number of approvals by regulatory authorities of new single-chambered type syringes.

Based on Product Type, the prefilled syringes market is segmented into Staked in-needle pre-filled syringes and Needle-free pre-filled syringes. Staked in-needle pre-filled syringes segment is expected to dominate the market over the forecast period and this is attributed to increase in the launch of safety systems for staked in-needle pre-filled syringes that can help prevent accidental needle stick injuries.

Based on Usability, the prefilled syringes market is segmented into Disposable and Reusable syringes. Disposable pre-filled syringes segment is expected to dominate the market over the forecast period and this is attributed to increase in the launch of disposable prefilled syringes by the key market players.

Based on Manufacturing Method, the prefilled syringes market is segmented into Captive and Merchant. Merchant segment is expected to dominate the market over the forecast period and this is attributed to market players outsourcing the manufacturing of their products to contract development and manufacturing organizations (CDMOs).

Based on End User, the prefilled syringes market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Others. Hospitals segment is expected to dominate the market over the forecast period and this is attributed to the development of smart concepts such as smart labels for prefilled syringes for optimizing hospital routine management.

Based on Region, Global Prefilled Syringes Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is expected to dominate the market over the forecast period and this is attributed to the increase in number of product approvals from regulatory authorities.

Among all segmentation, drug type segment has highest potential due to increasing expansions of biologics manufacturing, increasing launches of prefilled syringes for vaccinations and other factors. For instance, in September 2022, BD (Becton, Dickinson and Company), a global medical technology company, launched a next-generation glass prefilled syringe (PFS) named Effivax Glass Prefillable Syringe for administration of vaccines. Effivax glass prefillable syringe reduces risk of line stoppage, and improves the total cost of ownership, manufacturing, and supply availability.

Global Prefilled Syringes Market Cross Sectional Analysis:

In drug type segment, biologics segment is dominant in North America region due to increasing number of product launches or approvals containing monoclonal antibodies. For instance, in April 2021, Novartis, a pharmaceutical company, received the U.S. FDA approval for Xolair prefilled syringe for self-injection. Xolair contains omalizumab as active pharmaceutical ingredient and is indicated for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU), and nasal polyps.

In material segment, Plastic/ Polymer held as a dominant segment in Asia Pacific region due to the increasing launches by medical device companies in the region. For instance, in May 2022, Terumo Pharmaceutical Solutions (TPS), a pharmaceutical and medical device manufacturer based in Japan, launched a prefillable polymer syringe named PLAJEX for low-dose applications such as ophthalmic drugs. This is a Luer Lock Silicone oil-free pre-fillable syringe, and is used for lowdose Pre-Filled Syringe (PFS) products, which makes it suitable for high-value drug applications such as intravitreal injection.

Global Prefilled Syringes Market: Key Developments